| Issue Date | Title | Author(s) |
| 2011-11-21 | What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study | Jan, S; Usherwood, T; Brien, JA; Peiris, D; Rose, J; Hayman, N; Howard, K; Redfern, J; Laba, T; Cass, A; Patel, A |
| 2019-01-01 | Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-Analysis of randomised clinical trials | Selak, V; Webster, R; Stepien, S; Bullen, C; Patel, A; Thom, S; Arroll, B; Bots, ML; Brown, A; Crengle, S; Dorairaj, P; Elley, CR; Grobbee, DE; Harwood, M; Hillis, GS; Laba, TL; Neal, B; Peiris, D; Rafter, N; Reid, C; Stanton, A; Tonkin, A; Usherwood, T; Wadham, A; Rodgers, A |
| 2017-01-01 | Conversion of gestational diabetes mellitus to future Type 2 diabetes mellitus and the predictive value of HbA<inf>1c</inf> in an Indian cohort | Gupta, Y; Kapoor, D; Desai, A; Praveen, D; Joshi, R; Rozati, R; Bhatla, N; Prabhakaran, D; Reddy, P; Patel, A; Tandon, N |
| 2019-10-01 | Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial | Lung, T; Jan, S; de Silva, HA; Guggilla, R; Maulik, PK; Naik, N; Patel, A; de Silva, AP; Rajapakse, S; Ranasinghe, G; Prabhakaran, D; Rodgers, A; Salam, A; Selak, V; Stepien, S; Thom, S; Webster, R; Lea-Laba, T |
| 2018-08-01 | Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: Protocol for a qualitative study | Salam, A; Webster, R; Patel, A; Godamunne, P; Pathmeswaran, A; De Silva, HA; Rogers, A; Jan, S; Laba, TL |
| 2016-09-23 | An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: Protocol for a cluster randomized controlled trial | Hayek, A; Joshi, R; Usherwood, T; Webster, R; Kaur, B; Saini, B; Armour, C; Krass, I; Laba, TL; Reid, C; Shiel, L; Hespe, C; Hersch, F; Jan, S; Lo, S; Peiris, D; Rodgers, A; Patel, A |
| 2013-06-06 | INterpreting the Processes of the UMPIRE Trial (INPUT): Protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications | Salam, A; Stewart, F; Singh, K; Thom, S; Williams, HJ; Patel, A; Jan, S; Laba, T; Prabhakaran, D; Maulik, P; Day, S; Ward, H |
| 2015-01-01 | Patient Preferences for a Polypill for the Prevention of Cardiovascular Diseases | Laba, TL; Howard, K; Rose, J; Peiris, D; Redfern, J; Usherwood, T; Cass, A; Patel, A; Jan, S |
| 2015-09-23 | Implementing Kanyini GAP, a pragmatic randomised controlled trial in Australia: Findings from a qualitative study | Liu, H; Massi, L; Eades, AM; Howard, K; Peiris, D; Redfern, J; Usherwood, T; Cass, A; Patel, A; Jan, S; Laba, TL |
| 2017-06-23 | Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease | Angell, B; Laba, TL; Lung, T; Brown, A; Eades, S; Usherwood, T; Peiris, D; Billot, L; Hillis, G; Webster, R; Tonkin, A; Reid, C; Molanus, B; Rafter, N; Cass, A; Patel, A; Jan, S |
